A Comprehensive Review of the Treatment of Atopic Eczema

被引:60
作者
Lee, Ji Hyun [1 ]
Son, Sag Wook [2 ]
Cho, Sang Hyun [1 ]
机构
[1] Catholic Univ Korea, Dept Dermatol, Seoul, South Korea
[2] Korea Univ, Coll Med, Dept Dermatol, 73 Inchon Ro, Seoul 02841, South Korea
关键词
Eczema; atopic dermatitis; atopic eczema; treatment; prevention; epidemiology; TOPICAL CALCINEURIN INHIBITORS; INTERFERON-GAMMA-THERAPY; DOUBLE-BLIND; FLUTICASONE PROPIONATE; STAPHYLOCOCCUS-AUREUS; EPIDERMAL BARRIER; NATURAL-HISTORY; RISK-FACTORS; DERMATITIS; CHILDREN;
D O I
10.4168/aair.2016.8.3.181
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Atopic eczema (AE) is a chronic, inflammatory skin disorder which usually develops in early childhood. In spite of intensive investigations, the causes of AE remain unclear, but are likely to be multifactorial in nature. Environmental factors or genetic-environmental interactions seem to play a key role in disease progression. Among various measures of AE managment, cutaneous hydration, which improves barrier function and relieve itchiness, may be helpful to reduce the need for topical steroid use and therefore should be used as a basic treatment. Avoiding aggravating factors is also a basic treatment of AE. Standard medical treatment with a pharmacologic approach may be necessary if basic treatment fails to control symptoms satisfactorily. Recently, more attention is given to a proactive therapeutic by regular intermittent application of low potency steroids or topical calcineurin inhibitors to prevent new flares. Furthermore, various targeted biologics are being introduced for AE control and are proposed as promising therapies. This paper provides a summary of the recent literature on the manangement of AE and a treatment guideline.
引用
收藏
页码:181 / 190
页数:10
相关论文
共 94 条
  • [1] Are the new moisturizers more effective?
    Anderson, P. Chris
    Dinulos, James G.
    [J]. CURRENT OPINION IN PEDIATRICS, 2009, 21 (04) : 486 - 490
  • [3] [Anonymous], COCHRANE DATABASE SY
  • [4] Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis
    Arellano, Felix M.
    Wentworth, Charles E.
    Arana, Alejandro
    Fernandez, Carlos
    Paul, Carle F.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 (04) : 808 - 816
  • [5] Management of Difficult-to-Treat Atopic Dermatitis
    Arkwright, Peter D.
    Motala, Cassim
    Subramanian, Hamsa
    Spergel, Jonathan
    Schneider, Lynda C.
    Wollenberg, Andreas
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2013, 1 (02) : 142 - 151
  • [6] Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood:: ISAAC Phases One and Three repeat multicountry cross-sectional surveys
    Asher, M. Innes
    Montefort, Stephen
    Bjorksten, Bengt
    Lai, Christopher K. W.
    Strachan, David P.
    Weiland, Stephan K.
    Williams, Hywel
    [J]. LANCET, 2006, 368 (9537) : 733 - 743
  • [7] Asher MI, 1998, CLIN EXP ALLERGY, V28, P52
  • [8] Efficacy of allergen-specific immunotherapy for atopic dermatitis: A systematic review and meta-analysis of randomized controlled trials
    Bae, Jung Min
    Choi, Yoon Young
    Park, Chang Ook
    Chung, Kee Yang
    Lee, Kwang Hoon
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 132 (01) : 110 - 117
  • [9] Analysis of the Prevalence of and Risk Factors for Atopic Dermatitis Using an ISAAC Questionnaire in 8,750 Korean Children
    Baek, Jin-Ok
    Hong, Soyoung
    Son, Dong-Koog
    Lee, Jong-Rok
    Roh, Joo-Young
    Kwon, Ho-Jang
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2013, 162 (01) : 79 - 85
  • [10] Bamford JT, 2013, COCHRANE DB SYST REV, V4